Send me a link:

*Text messaging rates may apply.

 Dow Down 0.04% Nasdaq Up 0.28%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
49.77 Up 0.60(1.22%) 9:56AM EDT - Nasdaq Real Time Price
Prev Close:49.17
Open:49.32
Bid:49.28 x 100
Ask:49.69 x 200
1y Target Est:83.80
Beta:0.95
Next Earnings Date: 4-Aug-14LGND Earnings announcement
Day's Range:48.80 - 49.77
52wk Range:36.82 - 80.42
Volume:11,473
Avg Vol (3m):301,950
Market Cap:1.03B
P/E (ttm):85.37
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDUp 1.22%1.03B
LLYDown 0.51%65.11B
MRKUp 0.36%166.42B
RHHBYDown 0.25%246.20B

Key Statistics

Forward P/E (1 yr):20.45
P/S (ttm):19.13
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.44
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback